**Background of FGFRL1 Antibody**
FGFRL1 (Fibroblast Growth Factor Receptor-Like 1) is a transmembrane protein belonging to the fibroblast growth factor receptor (FGFR) family. Unlike canonical FGFRs, FGFRL1 lacks a tyrosine kinase domain, suggesting a unique regulatory role in FGFR signaling pathways. It is implicated in modulating cell adhesion, differentiation, and embryonic development, particularly in skeletal and craniofacial morphogenesis.
FGFRL1 antibodies are essential tools for detecting and studying the protein's expression, localization, and function. These antibodies are commonly used in techniques such as Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF) to investigate FGFRL1's role in physiological and pathological contexts. Research highlights its involvement in cancers (e.g., breast, lung) where aberrant FGFRL1 expression correlates with tumor progression and metastasis. Additionally, FGFRL1 mutations are linked to congenital disorders like craniofacial dysplasia.
Commercial FGFRL1 antibodies are typically raised against specific epitopes, often in rabbit or mouse hosts, and validated for specificity using knockout controls. Their applications extend to developmental biology, cancer research, and therapeutic target exploration. Ongoing studies aim to clarify FGFRL1's signaling mechanisms and its potential as a biomarker or drug target, driving demand for reliable antibodies in both basic and translational research.
(Word count: 198)